affected. Smoking increases the risk of disease and may worsen eye problems. The disorder results from an antibody, called thyroid-stimulating immunoglobulin (TSI), that has a similar effect to thyroid stimulating hormone (TSH). These TSI antibodies cause the thyroid gland to produce excess thyroid hormone. The diagnosis may be suspected based on symptoms and confirmed with blood tests and radioiodine uptake. Typically, blood tests show a raised T 3 and T 4 , low TSH, increased radioiodine uptake in all areas of the thyroid, and TSI antibodies. The three treatment options are radioiodine therapy, medications, and thyroid surgery. Radioiodine therapy involves taking iodine-131 by mouth, which is then concentrated in the thyroid and destroys it over weeks to months. The resulting hypothyroidism is treated with synthetic thyroid hormone. Medications such as beta blockers may control some of the symptoms, and antithyroid medications such as methimazole may temporarily help people while other treatments are having effect. Surgery to remove the thyroid is another option. Eye problems may require additional treatments. Graves' disease will develop in about 0.5% of males and 3% of females. It occurs about 7.5 times more often in women than in men. 1 Often, it starts between the ages of 40 and 60, but can begin at any age. It is the most common cause of hyperthyroidism in the United States (about 50 to 80% of cases). The exact cause is unclear; however, it is believed to involve a combination of genetic and environmental factors. While a theoretical mechanism occurs by which stress could cause an aggravation of the autoimmune response that leads to goitre disease, more robust clinical data are needed for a firm conclusion. Thyroidectomy is considered as a prompt therapy for multinodular goitre disease, but it has few disadvantages such as scar post operatively, need for hospitalization, operation complications, recurrent laryngeal nerve, hypoparathyroidism, and intra-operative bleeding. This study evaluates all the factors that cause intra-operative blood loss and how it affects the disease.
METHODS
This study was conducted on 200 patients with multinodular goitre disease, who underwent thyroidectomy during the period between November 2010 to July 2015.
The excluded patients were those who had undergone neck surgery before, those patients who had recurrent goiter, vocal cord paralysis, thyroid cancer requiring lymph node dessections. For a period of 14 days, all patients were administered with potassium iodide before the surgery. Conventional open surgery or neck surgery video assisted were performed. Closed suction drainage tubes before wound closure in all patients were given and removed them 1 to 3 days later. If voice change was observed, recurrent laryngeal nerve injury was recorded.
Those patients who had symptomatic hypocalcemia were given calcium supplements and vitamin D analogue.
Patients who within 12 months after surgery, who could discontinue the supplements and who could achieve normocalcemia were considered as transient hypocalcemia. Patients who had to continue the supplements for more than 12 months and who had < normal serum parathyroid harmone level were considered as permanent hypoparathyroidism. Variables of clinical were measured using AIOBL. To test the correlation between continuous variables and AIOBL, univariate analysis was performed. Students test, and regression analysis was used to compare between groups. A p value of less than 0.05 was said to be statistically significant. For multivariate analysis, P value of ≤0.10 was considered to be stepwise regression analysis to determine the risk factors for intra-operative bleeding.
RESULTS
The majority of patients were females which constitute about 76.3% with a median age of 33 years. The median period between the onset of the disease and operation was 15 months. Weight of thyroid in grams was 40. Postoperative hospital stay was 4 hours. Table 1 shows that the mean age in years of patients were 33, which ranged between 10 to 73 years, male to female ratio was 50:150. The period between disease onset and surgery was 15. Table 2 shows that intolerance to antithyroid drug and pre-operative β-blocker was the highest indication for surgery constituting 40% (80). The least was preoperative TSH at initial consultation (ng/mL) which constituted to 0.0-77.5 (0.004). Table 3 shows that duration of surgery in minutes was 185, amount of blood loss was 95 mL and 5 blood transfusions happened. Table 4 shows that open surgery:video assisted neck surgery was 120:70, subtotal:total/near total thyroidectomy was 135:55. Surgical complications were seen in 38 patients who had transient hypocalcemia and the least complications were seen in permanent recurrent laryngeal nerve palsy i.e. 0. Table 5 shows that regression analysis was done for age in years with correlation coefficient of 0.07, P-value of 0.25, BMI with correlation coefficient of 0.04, P value of 0.45, Period between disease onset and surgery with correlation coefficient of 0.34, P value of <0.001, Free T4 at initial consultation with correlation coefficient of 0.20, P value of <0.05 and weight of thyroid with correlation coefficient of 0.70, P-value of <0.0001.
DISCUSSION
Yamanouchi K et al reported that a total of 197 patients underwent thyroidectomy for multinodular goitre disease between 2002 and 2012. 6 It was evaluated that clinical factors that would be potentially related to AIOBL retrospectively. The median period between disease onset and surgery was 16 months (range: 1e480 months). Conventional surgery was performed in 125 patients, whereas video-assisted surgery was performed in 72 patients.
Subtotal and near-total/total thyroidectomies were performed in 137 patients and 60 patients, respectively. The median weight of the thyroid was 45 g (range: 7.3e480.0 g). Univariate analysis revealed that the strongest correlation of AIOBL was noted with the weight of thyroid (p <0.001). Additionally, AIOBL was correlated positively with the period be-tween disease onset and surgery (p <0.001) and negatively with preoperative free T4 (p <0.01). Multivariate analysis showed that only the weight of the thyroid was independently correlated with AIOBL (p < 0.001). Four patients (2.0%) needed blood transfusion, including two requiring autotransfusion, whose thyroids were all weighing in excess of 200 g.
The amount of drainage during the initial 6 hours and days until drain removal was correlated positively with AIOBL (p < 0.001, each). Occurrences of postoperative complications, such as recurrent laryngeal nerve palsy or hypoparathyroidism, and postoperative hospital stay were not correlated with AIOBL. Grodski S et al conducted a study in which the most frequent absolute indication was the presence of a large goiter (n = 8; 13%) or associated thyroid nodule (n = 6; 10%). 7 Ophthalmopathy, a relative indication, comprised the largest single group overall (n = 18; 29%); however, a significant number of patients (n = 17; 27%) elected surgery in the absence of a recognized indication. There was strong concordance (73%) between the recorded indication and the patients' survey response. Overall, there was a high level of satisfaction with surgery with 88% of respondents giving a satisfaction score of 7 or greater on a visual analog scale (VAS) (0-10). Erbil Y et al reported that the mean blood flow, MVD, CD-34 expression, and blood loss in group 1 patients were significantly lower than those in group 2 patients. 8 There was a negative correlation between Lugol solution treatment and blood flow (r(s) = -0.629; P = 0.0001), blood loss (r(s) = -0.621; P = 0.0001), MVD (r(s) = -0.865; P = 0.0001), and CD-34 expression (r(s) = -0.865; P = 0.0001). According to logistic regression analysis, Lugol solution treatment resulted in a 9.33-fold decreased rate of intraoperative blood loss. Karamanakos SN et al observed that a total, near-total and subtotal thyroidectomy was performed in 1,149,777 and 117 patients, respectively. 9 Transient RLNP occurred in 34 (1.6%) and permanent in 19 (0.9%) patients. Multivariate logistic regression analysis showed that extended resection (OR-odds ratio-1.6), Graves' disease (OR 2.7), thyroiditis (OR 2.1), recurrent goiter (OR 2.3) and thyroid malignancy (OR 1.7) were all independent risk factors for transient RLNP, whereas Graves' disease (OR 2.2) and recurrent goiter (OR 1.7) emerged as independent risk factors for permanent RLNP. The rates of transient and permanent hypoparathyroidism were 27.8% and 4.8%, respectively.
Multivariate analysis for transient hypoparathyroidism revealed that the extent of surgical resection (OR 2.2), Graves' disease (OR 2.1), recurrent goiter (OR 1.7), female gender (OR 1.5) and specimen weight (OR 1.6) were independent predictors. However, the extent of surgical resection (OR 2.7), Graves' disease (OR 1.8), recurrent goiter (OR 1.5) and malignant disease (OR 1.5) were independent risk factors for permanent hypoparathyroidism. Postoperative wound infection and hematoma occurred in 6 (0.3%) and 27 (1.3%) patients, respectively. No correlation was observed between wound infection or postoperative hemorrhage and the extent of surgery.
Allannic H et al performed a prospective randomized study was performed in patients with hyperthyroid Graves' disease (GD) in order to compare long (18 months) and short term (6 months) antithyroid drug treatment on the remission rate. 10 A therapeutic protocol was offered to all GD patients who had not been treated for this disease previously. All patients studied who followed the protocol were rechecked 2 yr after treatment was withdrawn, or earlier in the case of relapse. Of the patients having undergone long term treatment, 61.8% still were in remission 2 yr after treatment withdrawal, whereas only 41.7% of the patients treated for 6 months were in remission (P less than 0.05). Such findings clearly establish that treatment duration has a direct beneficial incidence on the remission rate. These results were confirmed by the fact that treatment for 18 months resulted in remission in 7 of 15 patients who had previously relapsed after a 6-month course of therapy. This improvement in relation to treatment duration might be due to the immunosuppressive action of carbimazole. No significant difference was observed between relapse and remission groups, regardless of treatment duration, for HLA ABDr, serum T3 and T4, and T3/T4 ratio determined before treatment. Only the thyroidstimulating antibody levels determined at the time of diagnosis and at the end of treatment were higher in the relapse group, a difference that was relevant only globally, due to value scattering. Thomusch Chiang FY et al conducted a study on 107 patients for clinically benign thyroid disease who underwent total thyroidectomies performed by the same surgeon between January 1987 and December 2004 were enrolled; 48 had Graves' disease and 59 had non-Graves' disease. 12 The rates of temporary vs permanent hypoparathyroidism, hematoma requiring surgical intervention, and temporary vs. permanent recurrent laryngeal nerve palsy (RLNP) after total thyroidectomy for benign thyroid disease were 34.6% vs. 3.7%, 6.5%, and 6.5% vs. 1.85%, respectively. The rates of permanent hypoparathyroidism and temporary RLNP in the Graves' disease group were significantly different when compared with the nonGraves' disease group (8.3% vs 0% and 11.5% vs 2.5%, respectively). However, comparing the rates of temporary hypoparathyroidism, permanent RLNP, and postoperative hematoma, there was no statistically significant difference. Compared with total lobectomy, the rates of postoperative hema-toma increased significantly for total thyroidectomy (6.5% vs 0.48%).
CONCLUSION
For multinodular goiter disease for excessive bleeding during surgery, a large goiter presented as a predictive factor, and transfusion of blood should be considered in cases in which goiter weighs more than 200 g.
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